GB2181647A - Compositions based on lysine and arginine salts - Google Patents
Compositions based on lysine and arginine salts Download PDFInfo
- Publication number
- GB2181647A GB2181647A GB08623076A GB8623076A GB2181647A GB 2181647 A GB2181647 A GB 2181647A GB 08623076 A GB08623076 A GB 08623076A GB 8623076 A GB8623076 A GB 8623076A GB 2181647 A GB2181647 A GB 2181647A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lysine
- arginine
- oleate
- test
- bht
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004472 Lysine Substances 0.000 title claims abstract description 28
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 title 1
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 13
- 229930195729 fatty acid Natural products 0.000 claims abstract description 13
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 13
- 239000004475 Arginine Substances 0.000 claims abstract description 10
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 4
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims abstract description 3
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 239000003921 oil Substances 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 26
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 25
- 238000012360 testing method Methods 0.000 description 21
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 19
- 229940049964 oleate Drugs 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 13
- 241000208818 Helianthus Species 0.000 description 12
- 235000003222 Helianthus annuus Nutrition 0.000 description 12
- HSQDJSAINPPZLR-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;octadecanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCCCCCCCC(O)=O HSQDJSAINPPZLR-ZSCHJXSPSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 10
- 244000144725 Amygdalus communis Species 0.000 description 9
- 235000011437 Amygdalus communis Nutrition 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 8
- 240000006497 Dianthus caryophyllus Species 0.000 description 7
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 7
- 244000000231 Sesamum indicum Species 0.000 description 7
- 235000003434 Sesamum indicum Nutrition 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- LTRDCMWQSHEEHZ-SKAGCHHQSA-N (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid (Z)-octadec-9-enoic acid Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.CCCCCCCC\C=C/CCCCCCCC(O)=O LTRDCMWQSHEEHZ-SKAGCHHQSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 150000002978 peroxides Chemical class 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 240000007817 Olea europaea Species 0.000 description 5
- 230000005587 bubbling Effects 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- -1 hydrocarbon radical Chemical group 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- 235000021313 oleic acid Nutrition 0.000 description 5
- 229960004063 propylene glycol Drugs 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- OCCJPJJUCIIHBF-VWMHFEHESA-N (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid hexadecanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.CCCCCCCCCCCCCCCC(O)=O OCCJPJJUCIIHBF-VWMHFEHESA-N 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 235000017060 Arachis glabrata Nutrition 0.000 description 4
- 244000105624 Arachis hypogaea Species 0.000 description 4
- 235000010777 Arachis hypogaea Nutrition 0.000 description 4
- 235000018262 Arachis monticola Nutrition 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 150000003862 amino acid derivatives Chemical class 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 4
- 229960002969 oleic acid Drugs 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 235000020232 peanut Nutrition 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- ALYQTSXGWBNEQC-VWMHFEHESA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;octadecanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.CCCCCCCCCCCCCCCCCC(O)=O ALYQTSXGWBNEQC-VWMHFEHESA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VFNKZQNIXUFLBC-UHFFFAOYSA-N 2',7'-dichlorofluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Cl)=C(O)C=C1OC1=C2C=C(Cl)C(O)=C1 VFNKZQNIXUFLBC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000001543 Corylus americana Nutrition 0.000 description 2
- 240000007582 Corylus avellana Species 0.000 description 2
- 235000007466 Corylus avellana Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- VHFSMDHANDABQK-UHFFFAOYSA-N azane;2-sulfanylpropanoic acid Chemical compound [NH4+].CC(S)C([O-])=O VHFSMDHANDABQK-UHFFFAOYSA-N 0.000 description 1
- OJHAHQJRQIOCFK-UHFFFAOYSA-N azane;chloroform;methanol Chemical compound N.OC.ClC(Cl)Cl OJHAHQJRQIOCFK-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Detergent Compositions (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Compositions for cosmetic, dermatological and/or alimentary use comprise salts resulting from the association of fatty acids with lysine or arginine of formula: <IMAGE> where R is a hydrocarbon radical straight or branched, saturated or mono-unsaturated comprising from 4 to 30 carbon atoms; and R' is -CH2- for lysine or <IMAGE> for arginine.
Description
SPECIFICATION
Compositions based on lysine and arginine
The invention relates to new compositions based on salts of lysine and of arginine, in which these basic amino acids are associated with fatty acids. Such associations have antioxidant, emulsifying and antiirritant properties, and can be used in cosmetic, dermatological, and even alimentary compositions, by reason of their biological nature and as they provide protection againsttheformation of pipoperoxides.
These compounds or associations correspond to thefollowing general formula:
in which R represents a hydrocarbon radical, straight or branched, saturated or mon-unsaturated comprising from 4to 30 carbon atoms, R' represents -CH2-for lysine or the guanidyl residue -C-NH-for arginine.
{
NH
Experience has shown thatthe use of polyunsaturated fatty acids leads to compositions which are badly tolerated on the skin surface.
These amino acid-fatty acid compounds can be produced by neutralization of the fatty acid with the basic amino acid, in such mannerthata hydroalcoho licsolutioncontaining 10% of one of the compounds shows a pH between 6.5 and 7.5. By way of example, one molecule of oleic acid (about 282 g) is dissolved in 500 to 750 ml of ethanol on a water bath at 50 C with agitation. One molecule of one ofthe amino acids is added slowly, (about 146 g for lysine or 174 g for agrinine). At a temperature not exceeding 55 C, in orderto avoid discolouration, and under reduced pressure, the alcohol and eventually the water is eliminated from the lysine base. In the case of unsaturated fatty acids like oleic or linoleic acids, gels of variable consistency are obtained.Saturated acids yield a solid mass, which can be ground and reduced to powder, and which is of colourvarying between white and beige.
The following Table gives the yields of fatty acids-amino acids, both theoretical and found, as well as the contents of total nitrogen, which determine the degree of purity ofthe product. The mono-unsaturated fatty acid derivatives give with water, in the cold, gels which liquefy on heating. They are soluble in ethanol pure and hydrated, in propylene glycol, and chloroform, but insoluble in acetone, and ethyl acetate. The saturated fatty acid derivatives take the form of powder, and are soluble, after heating, in propyleneglycol, and in glycerol. Theyform gels with water.They are partly soluble in chloroform and sparingly soluble in fats, like stearine, polyox yethylenefatty alcohols, and cetyl alcohol.
Calculated on the anhydrous products Fatty Theoretical mood Acid No. Fatty Amino Nitrogen Fatty Amino Mitrogen Acid Acid Acid Acid Derivates of Lyslne Stearic I 431| 65-8%| 34.2% 421 6.511 66.4k1 33.6% 6.3+ Palmitic 402 63.7%| 36.3% 6,9 % 6.9 64.8% 35.2% 6.72 Oleic 1 428 68.% 24,2% 6.5 % 66-8% 33.2% 6.4 Derivatives of Arginine Stearic 488 62.0% 62.0% 38.0% 12.22% 62.8% 62.8% 37.2%t 11.8% Oleic 486 456| 61.8% 38,2% 12,28% 61.2% 2.8% 12.2%
Identification
a) Melting Points (Maquenne Block)
Lysine oleate 150 +5 Arginine oleate 170 +5 Lysine palmitate 185 Arginine palmitate 135
Lysinestearate 190 " Argininestearate 170"
Lysine myristate 189 " b) Colour Reactions 1 - Into 2 ml of a hydroalcoholic solution, some drops of a ninhydrin solution are poured. The solution is held for some minutes on a boiling water bath. In all cases, there is obtained a brown violet colour.
2-Into 2 ml of a hydroalcoholicsolution, some drops of a sulphuric solution of paradimethylbenzaldehyde are poured. Awhite precipitate is produced.
The mixture is held over a water bath for some minutes, the precipitate disappears, and the solution take on a rose colour.
c) Examination by chromatographic plate
For characterization by yield of amino acid, there is usedthefollowing migration solvent: chloroform-methanol-ammonia: 20/20/10.
Migration period: about 30 minuts development: ninhydrin solution, methyl red of bromocresol purple.
Rf Rf
Lysine 0.35 Arginine 0.38
Lysine oleate 0.24 Arginine oleate 0.33
Lysine palmitate 0.23 Arginine palmitate 0.33 Lysinestearate 0.23 Argininestearate 0.33
Caprylate 0.23
For characterization by yield of fatty acid, there is used the following migration solvent: petroleum etherdiethylether: 50/50.
Developer: 2-7 dichlorofluorescein or methyl red.
After spraying with a solution of methyl red, the plate iswarmedandexposedwith ammoniavapour.The fatty acids and their amino acid derivatives remain red, while the exposed end of the plate becomes yellow. With the dichlorofluorescein, the plate is exposed to U.V. at 366 nm.
Rf Rf
Oleicacid 0.88 Arginineoleate 0.71
Stearic acid 0.66 Argininepalmitate 0.61
Palmitic acid 0.63 Arginine stearate 0.52
Lysine palmitate 0.61 Lysineoleate 0.72
Lysine stearate 0.55
d) Dosages
By acidification with hydrochloric acid of a solution
of one ofthe derivatives given below, the fatty acid is
easily separatedfrom the amino acid. The fatty acid
becomes supernatant, whilethe amino acid remains in the water phase in the form of hydrochloride. For the fatty acid, it is sufficientto determine the acidity
index to know its identity. Forthatthe amino acid, a test for nitrogen can be effected on the solution, or formaldehyde filtration may be effected.
These fatty acid-amino acid associations ofthe invention can be used alone as emulsifying and emollient agents, or in association with other emui- sifying agents, ionic ornon-ionic according to the final properties desired. Such substances can advan tageously be incorporated in compositions intended to be applied to the skin to remedy a deficiency in lipids as in water. They lead to a particularly oily touch without the inconvenience of a "greasy" character.
The principle other interest of these substances is their antioxidant property. Peroxides have a toxic characterwhich is not negligible, and the free radicals ofwhich are formed (peroxides and hydroperoxides) are not physiologically acceptable. Several authors have shown that it is wrong to attribute to peroxidation and radical oxidation in vivo an important part in the determination ofthe process of aging (HAR
MANN d-Free radicaltheoryofaging-J. Geront.
1968/23/476. Prolongation of life, Role ofthefree radical reaction in aging -J. Amer, Geront, Soc.
1969-17-721. HOCHSCHILD R-Lysosomes mem branes and aging Exp. Geront. 1971-6-153. TAPPELA L-Free radical lipid peroxydation damm and its inhibition by vitamin E and selenium - Fed. Proc.
1965-24-73). Ultraviolet radiation leads to theformation of peroxides (SHERVIN E Oxidation and antioxidants in fats and oil processing -J.A.O.C.S.
1978-55-809-VIGNERON M,Autoxidation. Mea suresforprevention 1956-Companyfor Pharmaceutical and Scientific Editions, Paris).These are factors in the aging ofthe skin, showing themselves by a loss of elasticity with the formation of wrinkles.
Protection against peroxidation is of interest, above all in summer because ofthe relatively high intensity of natural ionizing radiation.
Fatty acids like oleic acid are sensitive to autooxidation when not protected, and become antioxidants when they are associated with amino acids.
This is a particularly interesting property according to the invention.
The determination ofthe antioxidant properties of the lipid derivatives of lysine and of arginine has been the subject of numerous treatments of peroxide, after
bubbling with air and with oxygen, and principally afterexposureto ultraviolet radiation. Measurements
have been carried out on emulsions made with fatty acid-amino acid associations only, as the preparation of cosmetic compositions concerns above all emulsions. Comparative emulsions have been tested which do not contain test substances, but comprise only a polyoxythylenefatty alcohol inthe presence of
oil. Multiple oils, as well as oils emulsified with fatty
acid-amino acid associations have been tested. The
comaprisons have been made with common antiox
idant agents: butyl-hydroxytoluene (BHT) or butyl
hydroxy anisole (BHA). Oxidation ofthe oils was by bubbling airfor one hourat 50"C, in the presence of 2% and of 4% of lysine oleate, in comparison to an oil not treated but heated and an oil containing 0.1 % of
BHT: a) after bubbling; b) after6days; and c) after21 days.
TABLE 1
Content Neutral BHT Oils tested Time of Air Oleate test test after oleate treatment Sesame a) 2% 1.9 1.0 1.5 1.3 b) " 4.9 3.4 4.3 3.6 Carnation a) " 2.4 2.2 1.5 1.4 b) " 4.9 5.7 5.9 5.4 Sunflower a) " 1.4 3.5 1.6 0.4 b) " 3.8 3.5 3.3 3.2 Sweetalmond a) " 5.4 2.1 5.1 1.2 c) " 21.1 6.5 20.6 4.0 Soya a) " 15.0 8.4 17.4 18.1 c) " 29.4 20.4 31.3 27.1 Maize a) " 21.5 22.3 32.0 35.2 c) " 59.4 45.0 61.1 60.2 Peanut a) " 0.8 0.8 0.4 1.1 Olive a) " 2.9 3.8 1.8 1.3 Sweetalmond a) 4% 5.4 0.9 5.1 1.1 Olive a) " 2.9 1.2 1.8 1.3 The figures correspond to the numberofml of sodium hyposu Ifite N/200 per 1 g of oil.
Oxidation of oil by bubbling of oxygen during one hourat50eC. Measurements carried out immediately after treatm ent - Neutra i test without passage of 02.
Oxidation of oils. under U.V. at 50 --A)for 8 hours -B)for 12 hours. Comparison of protection between 2% lysine oleate and 0.1% BHT.
TABLE 2
Oleate Neutral BHT Test Oils Content Oxygen Oleate Test Test Carnation 2% 3.6 2.2 1.9 2.1 Hazelnut " 11.7 1.5 12.4 11.6 Second test " 11.7 1.4 12.3 11.7 Sesame " 1.4 1.2 lA 0.9 Oleicacid " 17.7 10.2 10.6 10.4 Sunflower 14.6 12.6 6.7 13.2 Peanut " 1.5 0.5 1.0 0.8 ; Glycerol Trioleate Sweet almond " 2.7 2.5 0.1 1.7 Sweet almond 4% 2.7 1.1 0.1 1.7 TABLE 3
Tested Oils Period of Test Oleate BHT Exposure Sunflower A 10.5 2.8 5.2 Peanut " 1.7 2.5 4.5 Carnation " 16.0 0.6 11.0 Maize " 9.7 0.7 7.6 Soya " 5.2 0.4 7.5 SweetAlmond" 7.1 1.7 3.8 Sesame " 3.8 0.7 2.2 Glycerol Trioleate Peanut B 4.1 1.4 3.2 Sesame " 10.3 3.2 6.2 Hazelnut " 16.5 2.1 5.8 SweetAlmond " 7.1 4.2 3.8 2% oleate SweetAlmond " " 7.1 1.8 3.8 4% oleate Oxidation of oils under U.V. for 10 hours Comparison of protection between 4% lysine stearate and 0.1 BHT.
TABLE 4
Oils tested Test Stearate BHT Sunflower 12.5 3.0 8.0 Carnation 13.2 0.5 8.5 Maize 10.7 0.6 3.5 Comparison of the antioxidant properties between 0.1% BHT, lysine oleate, and 5% lysine stearate, in the form of emulsion. Test: 5% test oil, 5% polyoxyethylene fatty acid 0.1% BHTintestoil-5% oleateand stearate, 5% test oil.
TABLE 5
Oils tested Test BHT Oleate Stearate Carnation 9.5 2.3 3.4 1.4 Sesame 22.5 3.7 4.4 1.4 SweetAlmond 12.0 2.0 2.1 0.6 Soya 11.4 4.2 4.6 2.3 Comparison of the antioxidant properties of different derivatives of lysine and ofarginine with BHT in different emulsified oils.
Test: polyoxyethylene alcohol 5% -5% oil -90% water BHT: 0.1 % in test emulsion
Amino acid derivatives: 5% - 5% oil - 90% water
Exposure U.V.:12 hours at 50 .
TABLE 6
Amino acid Oils Tested BHT Test Derivatives Lysine oleate Carnation 2.2 9.5 3.4 Sesame 3.7 22.1 4.4 Olive 2.2 8.4 2.0 SweetAlmond 2.0 12.0 2.1 Soya 4.0 11.5 4.6 Sunflower 2.8 36.0 1.5 Lysine Stearate Sesame 2.0 7.5 1.4 Carnation 1.4 2.2 1.4 Soya 3.0 15.5 2.3 Sweet Almond 1.5 7.6 0.7 Sunflower 2.8 36.0 4.1 Olive 2.2 8.4 1.5 Lysine Palmitate Sweet Almond 2.2 4.5 2.2 Sunflower 1.5 8.1 1.6 Arginine Oleate Sweet Almond 2.3 4.5 2.4 Sunflower 1.5 8.1 1.6 Arginine Palmitate Sweet Almond 2.3 4.5 2.1 Sunflower 1.5 - 8.1 1.3 Arginine Stereate Sweet Almond 2.3 4.7 1.8 Sunflower 1.5 9 1.2 Comparison ofthe antioxidant properties of different associations, fattyacid-amino acid with BHT, accordingto their introduction into the oily phase or the aqueous phase of an emulsion. Exposure to U.V.
18 hours at 22 . Emulsion, according toTable 6aqueous phase: (1)--oily phase (2). BHT is introduced only into the oily phase.
TABLE 7
Test oils in emulsion Amino acid derivatives Olive Sunflower Sweet Almond BHT 5 3.1 4 Test: fatty alcohol 13.5 13.1 10.2 +oil Lysine oleate (1) 5.7 4.7 2.0 (2) 3.2 3.4 1.7 Lysine stearate(1) 4.1 4.6 7.8 (2) 1.7 1.2 3.0 Lysinepalmitate(1) 1.6 4.4 4.8 (2) 1 0.8 3.2 Lysine myristate (1) 2.8 5.0 4.7 1.7 3.7 2.2 Arginineoleate(1) 4.4 5.2 5.5 (2) 3.5 2.6 3.2 Lysine caprylate (1) 4.5 6.0 5.8 2.7 4.4 3.8 The fatty acid-amino acid associations cannot be
put in parallel with classical chemical antioxidants, which are used in a weak dose, such as BHT and BHA for example. These associations are not properly
called antioxidants; they are principally emulsifying agents, with interesting emollient properties, char
acterised by antioxidant properties, which avoid
having to use chemical antioxidants.
In the light of numerous determinations of indices of peroxide, shown in the Tables, the following results are put in evidence: 1-By bubbling air or oxygen for one hourat 50 , lysine oleate is observed to lead to an antioxidant protection near or attimes superiorto that of BHT, according to the nature ofthe test oils (Tables 1 and 2).
2-By exposure to ultraviolet radiation during a period between 8 and eighteen hours, both the oleate and the stearate of lysine are effective antioxidants (Tables 3 and 4).
3-In the case of emulsions comprising different oils, exposed to U.V. during 18 hours, lysine stearate leads to results superiorto those obtained with the oleate (Table 5).
4-All the saturated fatty acid or mono-unsaturated fatty acid associations with lysine or arginine are endowed with antiperoxidant properties.
5-The antioxidant protection is higher when the amino acid derivatives are introduced into the oily phase of an emulsion, than in the aqueous phase.
By reason ofthe important of protection against ultraviolet radiation, it will be particularly advantageous to use this kind of substance, of strictly biological character the same as fatty acids and as freeorcombined lysineorarginine,which are normallyfound in tissue, and in particular at the level of the corneal layer, which allows themselves to opposethe disturbing action of solar radiation, relativetothe activity of peroxides.
Use of associations of faffy acids--lysine orarginine Given on the one hand, as has been stated, that there is interest in introducing these associations into fats to protect against auto-oxidation, but on the other hand the fact of high melting points, it is difficult to obtain a homogeneous and limpid mixture, without causing modification ofthe colour ofthe fat, it is preferableto solubilize them in polya Icohols like propyleneglycol or glycerol for example and to introduce this mixture into the fat. Thus there is obtained a limpid mass which, on addition of water, leads to the desired emulsion. Emulsions are then obtained of which the pH is about 7 and which are characterised by a remarkable emollient action.
Byway of non-limiting examples, there are cited as emulsion compositions:
1) Lysineoleate 5 Propyleneglycol 10
Cetyl .................................... alcohol 5 Stearine ...... ... ... 10 Water 100
Preservative qs 2) Lysinestearate 5 5 Propyleneglycol ............................... 10
Stearine 10
Polyoxyethylene fatty alcohol 5 Sweetalmondoil 5 Water 100
Preservative qs
3) Arginineoleate ................................. 5
Glycerol ........................................ 10 Sunflower 10 Polyoxyethylenecetylalcohol 10
Stearine .......... ............. ............ 8
Lipoaminoacid 3
Waterqs 100
Preservative qs
One can use, equally, advantageously these associations in hygiene products, such as soaps, shampoos by reason of their emollient and very slippery properties. It will be the same for the preparation of permanent waving solutions in which this kind of association will permit an increase in activity of reducing components, by virtue oftheirtensioactivity, on the one hand and on the other hand by reason ofthe biological nature ofthis kind of substance.
As non-limiting examples, there is mentioned:
1) Toilet soap
Cocoa-pa Imistic soap 95 Lysineoleate 5 Coconut oil ................................ soap 95 Lysinestearate 5
2) Shampoos
Sodium laurylsulphate 30 Lysineoleate 5 Water ........................................ 65 Etherlaurylsulphate 20
Sodium laurylcollagenate ................. 10 Lysineoleate 5 Water ........................................ 65
3) Permanent waving lotion Ammoniumthiolactate 15 15 Lysineoleate 2 Ammonia ........................................ 70 Water ............... ....... . 73
Claims (7)
1. Compositionsforcosmetic, dermatological andlor alimentary use which comprise salts resulting from the association of fatty acids with Iysine or arginine, corresponding to the following general formula:
in which R represents a hydrocarbon radical straight or branched, saturated or mono-unsaturated comprising from 4to 30 carbon atoms; and
R' represents -CH2-for lysine ora guanidyi residue -C-NH-forarginine.
# NH
2. Cosmeticand/ordermatological compositions according to claim 1 in combination with other emulsifiers.
3. Cosmetic, dermatological and/or alimentary compositions according to claim 1 substantially as herein described.
4. A process of producing a composition according to claim 1 which comprises neutralization ofthe fatty acid with the basic amino acid.
5. A process according to claim 4 which is performed in a hydroalcoholic solution at a pH between
6.5 and
7.5.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8514536A FR2587900B1 (en) | 1985-10-01 | 1985-10-01 | BASIC FATTY-AMINO ACID ASSOCIATIONS WITH EMOLLIENT, EMULSIFIING AND ANTIOXIDANT PROPERTIES FOR COSMETICS, DERMATOLOGY AND FOOD |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8623076D0 GB8623076D0 (en) | 1986-10-29 |
| GB2181647A true GB2181647A (en) | 1987-04-29 |
| GB2181647B GB2181647B (en) | 1989-10-11 |
Family
ID=9323421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8623076A Expired GB2181647B (en) | 1985-10-01 | 1986-09-25 | Compositions based on lysine and arginine salts. |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS6289646A (en) |
| DE (1) | DE3633453A1 (en) |
| FR (1) | FR2587900B1 (en) |
| GB (1) | GB2181647B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2209120A (en) * | 1987-08-28 | 1989-05-04 | Hoerrmann Wilhelm | Anti-tumour compositions containing lysine derivatives |
| FR2628419A1 (en) * | 1988-03-09 | 1989-09-15 | Biorex Kft | NOVEL ANTIVIRAL SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR THEIR PREPARATION |
| GB2226759A (en) * | 1987-12-30 | 1990-07-11 | Wilhelm Hoerrmann | Pharmaceutical compositions containing lysine |
| FR2673373A1 (en) * | 1991-03-01 | 1992-09-04 | Bague Jean Claude | COMPOSITIONS FOR MAKEUP COMPRISING FATTY ACID-BASIC AMINO ACID ASSOCIATIONS FOR FIXING WATER-SOLUBLE COLORING MATERIALS TO THE SKIN. |
| FR2747309A1 (en) * | 1996-04-16 | 1997-10-17 | Morelle Jean | Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity |
| WO2008006721A1 (en) * | 2006-07-14 | 2008-01-17 | Unilever Plc | Hair care composition |
| US20110240050A1 (en) * | 2010-04-01 | 2011-10-06 | L'oreal S.A. | Cosmetic compositions containing a fatty acid, arginine, and a co-emulsifier |
| ITMI20111617A1 (en) * | 2011-09-08 | 2013-03-09 | Euro Kemical S R L | COSMETIC COMPOSITION BASED ON BABASSU OIL |
| US8440172B2 (en) | 2007-07-09 | 2013-05-14 | Symrise Ag | Stable soluble salts of phenylbenzimidazole sulfonic acid at PHS at or below 7.0 |
| US20220312803A1 (en) * | 2021-03-30 | 2022-10-06 | Apeel Technology, Inc. | Edible barrier film composition |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2609998B1 (en) * | 1987-01-26 | 1994-04-15 | Morelle Jean | NOVEL ANTIOXIDANT SUBSTANCES DERIVED FROM AMINO ACIDS |
| JP2525214B2 (en) * | 1987-12-25 | 1996-08-14 | チッソ株式会社 | Ferroelectric liquid crystal composition |
| WO1992006667A1 (en) * | 1990-10-19 | 1992-04-30 | Shiseido Company, Ltd. | External preparation for skin |
| DE4341001A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Topical preparations containing L-arginine |
| DE19713776A1 (en) * | 1997-04-03 | 1998-10-08 | Beiersdorf Ag | Light protection preparations with a content of basic amino acids and water-soluble UV filter substances |
| FR2908300B1 (en) * | 2006-11-10 | 2012-08-24 | Oreal | COSMETIC COMPOSITION COMPRISING C16-C-30 FATTY ACID AND BASIC ACID, METHODS AND USES. |
| EP1920760A1 (en) * | 2006-11-10 | 2008-05-14 | L'Oréal | Cosmetic composition comprising a compound chosen from amino acid salts and derivatives |
| DE102009034771B4 (en) | 2009-07-25 | 2011-09-01 | Martin Schmitt | Skin protectant |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0069659A1 (en) * | 1981-07-03 | 1983-01-12 | CHANY, Charles | Medicine containing the reaction product of a carboxylic acid and a basic amino acid |
| EP0078785A1 (en) * | 1981-11-04 | 1983-05-11 | "PHARLYSE", Société Anonyme | Salts of valproic acid, their preparation and their use |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945049A (en) * | 1959-05-25 | 1960-07-12 | Gen Mills Inc | Salts of basic amino acids and linoleic acid |
| LU54223A1 (en) * | 1967-08-01 | 1969-03-24 | ||
| FR1583104A (en) * | 1968-08-02 | 1969-10-17 | ||
| FR2104992A1 (en) * | 1970-09-09 | 1972-04-28 | Melle Bezons | Recovering organic arginine salts - by discharging a spray of soln into hot air current |
| JPS537492B2 (en) * | 1973-02-12 | 1978-03-18 | ||
| JPS5738640B2 (en) * | 1974-02-05 | 1982-08-17 | ||
| JPS52156787A (en) * | 1976-06-23 | 1977-12-27 | Shiseido Co Ltd | Oil-in-water type emulsified composition |
| US4400295A (en) * | 1979-03-24 | 1983-08-23 | Loire Cosmetics Co., Ltd. | Emulsifier composition |
| JPS5653196A (en) * | 1979-10-08 | 1981-05-12 | Mitsui Toatsu Chemicals | Surfactant composition |
| JPS5670098A (en) * | 1979-11-14 | 1981-06-11 | Mitsui Toatsu Chemicals | Surfactant composition |
| JPS56103104A (en) * | 1980-01-19 | 1981-08-18 | Shiseido Co Ltd | O/w type emulsion compositon |
| JPS57125298A (en) * | 1981-01-27 | 1982-08-04 | Mitsui Toatsu Chemicals | Amino acid-added fatty acid type surfactant composition |
| EP0126348A2 (en) * | 1983-05-19 | 1984-11-28 | Kyoto Pharmaceutical Industries, Ltd. | Composition for rectal administration and method of promoting rectal drug absorption |
-
1985
- 1985-10-01 FR FR8514536A patent/FR2587900B1/en not_active Expired
-
1986
- 1986-09-25 GB GB8623076A patent/GB2181647B/en not_active Expired
- 1986-10-01 JP JP61234225A patent/JPS6289646A/en active Pending
- 1986-10-01 DE DE19863633453 patent/DE3633453A1/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0069659A1 (en) * | 1981-07-03 | 1983-01-12 | CHANY, Charles | Medicine containing the reaction product of a carboxylic acid and a basic amino acid |
| EP0078785A1 (en) * | 1981-11-04 | 1983-05-11 | "PHARLYSE", Société Anonyme | Salts of valproic acid, their preparation and their use |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2209120A (en) * | 1987-08-28 | 1989-05-04 | Hoerrmann Wilhelm | Anti-tumour compositions containing lysine derivatives |
| GB2209120B (en) * | 1987-08-28 | 1992-01-15 | Hoerrmann Wilhelm | Drugs containing lysine or hydroxylysine derivatives |
| GB2226759A (en) * | 1987-12-30 | 1990-07-11 | Wilhelm Hoerrmann | Pharmaceutical compositions containing lysine |
| FR2628419A1 (en) * | 1988-03-09 | 1989-09-15 | Biorex Kft | NOVEL ANTIVIRAL SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR THEIR PREPARATION |
| GB2216522A (en) * | 1988-03-09 | 1989-10-11 | Biorex Kft | Aminoacid salts of long chain unsaturated carboxylic acids |
| GB2216522B (en) * | 1988-03-09 | 1992-01-02 | Biorex Kft | Amino acid salts of long chain unsaturated fatty acid |
| BE1003663A3 (en) * | 1988-03-09 | 1992-05-19 | Biorex Kft | NEW ANTIVIRAL SALTS, pharmaceutical compositions containing AND METHOD FOR PREPARING. |
| AT398073B (en) * | 1988-03-09 | 1994-09-26 | Biorex Kutato Fejlesztoe Kft | ANTIVIRAL AND IMMUNOTIMULATING NEW SALTS, AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| WO1992015277A1 (en) * | 1991-03-01 | 1992-09-17 | Bague Jean Claude | Cosmetic compositions for make-up and make-up removal |
| FR2673373A1 (en) * | 1991-03-01 | 1992-09-04 | Bague Jean Claude | COMPOSITIONS FOR MAKEUP COMPRISING FATTY ACID-BASIC AMINO ACID ASSOCIATIONS FOR FIXING WATER-SOLUBLE COLORING MATERIALS TO THE SKIN. |
| FR2747309A1 (en) * | 1996-04-16 | 1997-10-17 | Morelle Jean | Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity |
| WO2008006721A1 (en) * | 2006-07-14 | 2008-01-17 | Unilever Plc | Hair care composition |
| US8440172B2 (en) | 2007-07-09 | 2013-05-14 | Symrise Ag | Stable soluble salts of phenylbenzimidazole sulfonic acid at PHS at or below 7.0 |
| US20110240050A1 (en) * | 2010-04-01 | 2011-10-06 | L'oreal S.A. | Cosmetic compositions containing a fatty acid, arginine, and a co-emulsifier |
| ITMI20111617A1 (en) * | 2011-09-08 | 2013-03-09 | Euro Kemical S R L | COSMETIC COMPOSITION BASED ON BABASSU OIL |
| US20220312803A1 (en) * | 2021-03-30 | 2022-10-06 | Apeel Technology, Inc. | Edible barrier film composition |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2587900A1 (en) | 1987-04-03 |
| JPS6289646A (en) | 1987-04-24 |
| DE3633453A1 (en) | 1987-04-02 |
| GB2181647B (en) | 1989-10-11 |
| FR2587900B1 (en) | 1988-10-07 |
| GB8623076D0 (en) | 1986-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2181647A (en) | Compositions based on lysine and arginine salts | |
| US5520918A (en) | Low irritant skin-cosmetic composition for daily topical use, its application and manufacture | |
| JP2003533491A (en) | Pharmaceutical and / or cosmetic composition | |
| KR930007911B1 (en) | External preparation to prevent coloring | |
| BRPI0115953B1 (en) | phosphate derivative complexes | |
| JPS59500129A (en) | Sebum-inhibiting cosmetic agent containing long-chain alkanol and antioxidant | |
| MXPA00003830A (en) | Coloring agent-containing sunless tanning compositions. | |
| JPS6330884B2 (en) | ||
| EP0686027B1 (en) | Verwendung eines phenolischen Diterpens zur Herstellung einer Zusammensetzung zur therapeutischen Verwendung auf der Haut | |
| JP2552297B2 (en) | Beautiful skin cosmetics | |
| JPH0545569B2 (en) | ||
| JP2009507016A (en) | Novel skin care composition | |
| KR101072198B1 (en) | Cosmetic composition for skin whitening | |
| JP2552298B2 (en) | Beautiful skin cosmetics | |
| EP1526849B1 (en) | Topical formulations containing ketoprofen stabilised with sulisobenzone | |
| JP2845466B2 (en) | Liposomes containing hydroquinone and kojic acid, and pharmaceutical compositions, especially dermatological compositions having skin lightening activity and anti-inflammatory activity, or cosmetics containing liposomes containing kojic acid and hydroquinone The active ingredient composition used for preparing a pharmaceutical composition or a cosmetic composition characterized by comprising: | |
| JP4227332B2 (en) | Pyridoxine derivatives, and skin cosmetics and hair cosmetics containing the pyridoxine derivatives | |
| JPH08301745A (en) | Skin cosmetic | |
| JPH0780739B2 (en) | Antioxidant system and compositions containing same | |
| JP3656197B2 (en) | Topical skin preparation | |
| EP1025838B1 (en) | A cosmetic composition and a method for reducing the ageing processes of skin | |
| JPH0692833A (en) | Skin external agent | |
| JPH072640A (en) | External preparation for protecting ultraviolet disorder | |
| JPH06316553A (en) | Application of alkanolamine | |
| JP2774063B2 (en) | Antioxidant composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930925 |